An Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of a Bivalent Klebsiella Pneumoniae Vaccine (CHO-V08) in Healthy Adults

Clinical trial NCT07016152 · RECRUITING

Trial details

NCT number: NCT07016152
Sponsor: Cho Pharma Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Klebsiella Pneumoniae Infection Vaccine

Start date: 2025-06-26
Primary completion: 2026-11-05
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.